PhageLytiX has designed multiple  phage cocktails boasting an expansive host range tailored to effectively target and lyse multidrug-resistant (MDR) and extensively drug-resistant (XDR) pathogens. Specifically designed to combat formidable bacterial adversaries such as Salmonella, Shigella, Escherichia coli, Klebsiella, Acinetobacter, and Burkholderia, our meticulously developed cocktail demonstrates remarkable efficacy in neutralizing these challenging pathogens. With precision engineering and rigorous testing, our phage cocktail stands poised as a formidable tool in the ongoing battle against antibiotic resistance, offering a promising avenue for combating infectious diseases caused by these resilient bacterial strains. Recently our team has   designed a phage preparation named PLytix cocktail 2.1 which has capability to target multiple  MDR and XDR Uropathogenic E.coli isolates